As in univariate analysis, high MYO1E RNA overexpression in NSCLC was also associated with higher mortality risk when compared with those of lower MYO1E RNA expression (HR 1.69, 95% CI: 1.02–2.79) (Supplemental Fig. 4). This evidence concerns the gene MYO1E and non-small cell lung carcinoma.